Enhanced mathematical model of postprandial glycemic excursion in diabetics using rapid-acting insulin

被引:0
|
作者
Noguchi, Claudia Cecilia Yamamoto [1 ]
Furutani, Eiko [1 ]
Sumi, Shoichiro [2 ]
机构
[1] Kyoto Univ, Dept Elect Engn, Kyoto 6158510, Japan
[2] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan
关键词
glucose-insulin model; postprandial glycemia; insulin-dependent diabetes; Bergman minimal model; Shimoda insulin model; glycemic index; glucose relative response; INTRAVENOUS GLUCOSE; CARBOHYDRATE;
D O I
暂无
中图分类号
TP301 [理论、方法];
学科分类号
081202 ;
摘要
We present some improvements to our previous model of postprandial glucose excursion in diabetics under rapid-acting insulin therapy. In the glucose sub-model, we correct Glycemic Index values from the glucose relative function and as a result, adjust absorption rate parameters for carbohydrates. In the insulin sub-model, we modify Shimoda insulin model parameters to obtain a more realistic representation of the effect of rapid-acting insulin on glycemic levels. Additionally, we derive a more intelligible expression of the relative exogenous insulin function. Results from computer simulations show that our enhanced model is now accurate throughout the GI range of carbohydrates.
引用
收藏
页码:566 / 571
页数:6
相关论文
共 50 条
  • [31] The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences
    Home, P. D.
    DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 780 - 788
  • [32] Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues
    Kamal, Ali D.
    Bain, Stephen C.
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (01) : 5 - 7
  • [33] Technosphere insulin provides better early postprandial glucose control than s.c. rapid-acting analogue
    Grant, M.
    Pompilio, F.
    Sharma, G.
    Zaveri, N.
    Krueger, J.
    Kendall, D.
    DIABETOLOGIA, 2019, 62 : S94 - S94
  • [34] Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, is independent of hepatic function
    Lyness, W
    Tyler, J
    Lawrence, A
    DIABETES, 2001, 50 : A442 - A442
  • [35] Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart
    Heinemann, L
    Weyer, C
    Rauhaus, M
    Heinrichs, S
    Heise, T
    DIABETES CARE, 1998, 21 (11) : 1910 - 1914
  • [36] Preclinical safety pharmacology studies on the rapid-acting insulin analogue insulin aspart
    Dall, V
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1999, 49 (05): : 463 - 470
  • [37] Examining the Glycemic and Hypoglycemic Benefits with Rapid-Acting Insulin Analogs: A Meta Analysis of Insulin Aspart vs Regular Human Insulin in Randomized Controlled Trials
    Heller, Simon
    Bode, Bruce W.
    Kozlovski, Plamen
    Svendsen, Anne Louise
    DIABETES, 2009, 58 : A135 - A135
  • [38] Insulin Biosimilars: The Impact on Rapid-Acting Analogue-Based Therapy
    Franze, S.
    Cilurzo, F.
    Minghetti, P.
    BIODRUGS, 2015, 29 (02) : 113 - 121
  • [39] INPATIENTS HYPERGLYCAEMIC CONTROL BY BASAL/BOLUS RAPID-ACTING INSULIN INJECTION
    Bellido, I.
    Vazquez-Marquez, M.
    Gomez-Huelgas, R.
    Lopez-Carmona, M.
    Jansen, S.
    Sobrino, B.
    Chaves, M.
    Martin-Gallardo, P.
    Garcia-Fernandez, C.
    Bernal-Lopez, M.
    Blanco, E.
    Garcia-Arnes, J.
    Marquez, E.
    de Pablo, J.
    Gomez-Luque, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 243 - 243
  • [40] Comparison of Zn Content in Rapid-acting Insulin and Biphasic Suspension by FAAS
    Shkunnikova, Sofia
    Sirac, Tea
    Lalic, Katarina
    Kulisic, Ankica
    Jablan, Jasna
    CROATICA CHEMICA ACTA, 2021, 94 (02)